These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 32852886)

  • 1. Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice.
    Feng T; Mai S; Roscoe JM; Sheng RR; Ullah M; Zhang J; Katz II; Yu H; Xiong W; Hu F
    EMBO Rep; 2020 Oct; 21(10):e50219. PubMed ID: 32852886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
    Zhou X; Sun L; Brady OA; Murphy KA; Hu F
    Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.
    Zhou X; Brooks M; Jiang P; Koga S; Zuberi AR; Baker MC; Parsons TM; Castanedes-Casey M; Phillips V; Librero AL; Kurti A; Fryer JD; Bu G; Lutz C; Dickson DW; Rademakers R
    EMBO Rep; 2020 Oct; 21(10):e50197. PubMed ID: 32761777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function.
    Brady OA; Zheng Y; Murphy K; Huang M; Hu F
    Hum Mol Genet; 2013 Feb; 22(4):685-95. PubMed ID: 23136129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice.
    Werner G; Damme M; Schludi M; Gnörich J; Wind K; Fellerer K; Wefers B; Wurst W; Edbauer D; Brendel M; Haass C; Capell A
    EMBO Rep; 2020 Oct; 21(10):e50241. PubMed ID: 32929860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FTLD Risk Factor TMEM106B Regulates the Transport of Lysosomes at the Axon Initial Segment of Motoneurons.
    Lüningschrör P; Werner G; Stroobants S; Kakuta S; Dombert B; Sinske D; Wanner R; Lüllmann-Rauch R; Wefers B; Wurst W; D'Hooge R; Uchiyama Y; Sendtner M; Haass C; Saftig P; Knöll B; Capell A; Damme M
    Cell Rep; 2020 Mar; 30(10):3506-3519.e6. PubMed ID: 32160553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.
    Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A
    Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by
    Holler CJ; Taylor G; Deng Q; Kukar T
    eNeuro; 2017; 4(4):. PubMed ID: 28828399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
    Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
    Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes.
    Tanaka Y; Suzuki G; Matsuwaki T; Hosokawa M; Serrano G; Beach TG; Yamanouchi K; Hasegawa M; Nishihara M
    Hum Mol Genet; 2017 Mar; 26(5):969-988. PubMed ID: 28073925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelination.
    Zhang T; Feng T; Wu K; Guo J; Nana AL; Yang G; Seeley WW; Hu F
    Acta Neuropathol; 2023 Jul; 146(1):97-119. PubMed ID: 37120788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.
    Klein ZA; Takahashi H; Ma M; Stagi M; Zhou M; Lam TT; Strittmatter SM
    Neuron; 2017 Jul; 95(2):281-296.e6. PubMed ID: 28728022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
    Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
    Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lysosomal protein cathepsin L is a progranulin protease.
    Lee CW; Stankowski JN; Chew J; Cook CN; Lam YW; Almeida S; Carlomagno Y; Lau KF; Prudencio M; Gao FB; Bogyo M; Dickson DW; Petrucelli L
    Mol Neurodegener; 2017 Jul; 12(1):55. PubMed ID: 28743268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice.
    Feng T; Du H; Yang C; Wang Y; Hu F
    Acta Neuropathol; 2024 Mar; 147(1):62. PubMed ID: 38526799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration.
    Reich M; Simon MJ; Polke B; Paris I; Werner G; Schrader C; Spieth L; Davis SS; Robinson S; de Melo GL; Schlaphoff L; Buschmann K; Berghoff S; Logan T; Nuscher B; de Weerd L; Edbauer D; Simons M; Suh JH; Sandmann T; Kariolis MS; DeVos SL; Lewcock JW; Paquet D; Capell A; Di Paolo G; Haass C
    Sci Transl Med; 2024 Jun; 16(750):eadj7308. PubMed ID: 38838131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.
    Zhou X; Kukar T; Rademakers R
    Adv Exp Med Biol; 2021; 1281():219-242. PubMed ID: 33433878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.